Le Lézard
Classified in: Health, Science and technology
Subjects: CCA, TDS

Digital Clinical Trials: Avoiding Pitfalls with Intelligent Study Design, Upcoming Webinar Hosted by Xtalks


In this free webinar, learn how adaptive protocols can enable medical device sponsors to merge Phase II and Phase III objectives into a single trial, saving precious time and budget. Attendees will learn how to rigorously screen patients and successfully train them remotely on device use and data collection. The featured speakers will discuss how virtual site teams can keep participants engaged while also ensuring electronic patient-reported outcome compliance.

TORONTO, March 6, 2024 /PRNewswire-PRWeb/ -- Why test a medical device in-clinic when patients will have to manage its use on their own from home?

Panelists will also reveal how collaboration and iteration helped to identify and mitigate many of the study's risks from the outset.

This question directed Mi-Helper, Inc. Founder and CEO, Steve Schaefer, toward a digital clinical trial design for his migraine medical device. The resulting trial journey, which he assumed would be relatively linear, was anything but that. He had to figure out how to keep his participants engaged during a long run-in period and ensure they used his device properly at home. Resolving this complexity was essential for him to feel confident he would get the pristine data needed for regulatory submissions.

This webinar will focus on the design and deployment of a remote medical device trial. The trial's sponsor, members of the study's clinical operations team and an expert neurologist will provide a 360° view of the challenges associated with conducting medical device clinical trials. Panelists will also reveal how collaboration and iteration helped to identify and mitigate many of the study's risks from the outset.

The attendees will get to learn more about the fundamentals of this clinical trial's success: i) meticulous study design, ii) a comprehensive patient training program and iii) a real-human virtual site team that supported patients and kept them on track throughout their clinical trial journey.

Register for this webinar today to gain insights into designing digital clinical trials for medical devices and related challenges.

Join moderator Florence Mowlem, PhD, VP of Science, ObvioHealth; and panelists Steve Schaefer, Chief Executive Officer, Mi-Helper, Inc.; Matty Lynch, Chief Operations Officer, ObvioHealth; and Larry Charleston IV, MD MSc FAHS, Professor, Department of Neurology, Michigan State University, and Co-Founder, Chief Consultant, and CEO, Charleston Health Neurology & Head Pain Consultants, PLLC, for the live webinar on Monday, March 25, 2024, at 10am EDT (3pm CET/EU-Central).

For more information, or to register for this event, visit Digital Clinical Trials: Avoiding Pitfalls with Intelligent Study Design.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars and digital content to the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps professionals stay current with industry developments, regulations and jobs. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit https://xtalks.com
For information about hosting a webinar visit https://xtalks.com/why-host-a-webinar/

Media Contact

Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, [email protected], https://www.xtalks.com 

SOURCE Xtalks


These press releases may also interest you

at 08:30
Toitures Hogue's commitment to providing its employees with a structured, professional working environment that guarantees complete safety in the workplace, both on the job and on the job site, has just been awarded its renewed ISO 45001...

26 avr 2024
The report titled "Anti-Mullerian Hormone Test Market by Product (POC Testing, Self-check Kits), End-User (Commercial Labs, Research & development), Distribution, Use - Global Forecast 2024-2030" is now available on 360iResearch.com's offering,...

26 avr 2024
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...

26 avr 2024
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the...

26 avr 2024
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...

26 avr 2024
David J. Dykeman, co-chair of the Life Sciences & Medical...



News published on and distributed by: